Skip to main content
. Author manuscript; available in PMC: 2006 Jun 5.
Published in final edited form as: Mol Ther. 2005 Sep 2;13(1):151–159. doi: 10.1016/j.ymthe.2005.07.688

TABLE 4.

Duration of antigen-specific recognition by p53 TCR-electroporated PBLs

Days post-EP (IFN-γ, pg/ml)
Peptide/T2 EP/PBL 1 2 3 4 5 7 8
p53 (264–272) GFP 440 (±200) 510 (±261) 531 (±115) 1035 (±1090) 0 85 (±15) 60 (±14)
p53 66,600 (±4640) 45,141 (±4350) 33,665 (±2901) 19,345 (±1985) 2351 (±275) 530 (±190) 152 (±17)
NY-ESO-1 GFP 358 (±86) 498 (±24) 551 (±51) 492 (±140) 27 (±0) 55 (±5) 64 (±28)
p53 632 (±124) 1347 (±129) 499 (±107) 421 (±250) 0 45 (±30) 107 (±10)
No peptide GFP 400 (±294) 666 (±435) 1010 (±890) 505 (±230) 35 (±0) 75 (±15) 57 (±19)
p53 440 (±94) 1218 (±159) 480 (±56) 335 (±210) 60 (±0) 60 (±10) 107 (±5)

PBLs were stimulated with OKT3 for 3 days and electroporated with p53-specific TCR or GFP RNA. Electroporated PBLs were cocultured with peptide-pulsed T2 cell line at the days indicated and IFN-γ secretion was detected by ELISA. Values are means of triplicate samples (SD). Data are representative of two experiments.